Vitamin D is synthesized by our body, at the level of the epidermis, through the absorption of sunlight rays and is essential for our health, especially for bones and the functioning of the immune system. Several studies, however, have confirmed that a large part of the population is deficient in Vitamin D. This deficiency can lead to serious health problems such as osteomalacia and rickets.

Supplementation with vitamin D is therefore essential. However, not all supplements are equally effective, and the assimilation of the vitamin can vary significantly. This is where the innovation of IPS products comes into play.

IPS, a leading company in the market of microencapsulated raw material, has addressed the issue of the assimilation of vitamin D through a technique called microencapsulation by coacervation.

This technique allows to protect the active ingredient dispersed in oil from physical degradation, and to optimally convey vitamin D3 (particularly cholecalciferol) within the gastrointestinal tract.

The titration of the microcapsules ranges from 80% to 90%, with a concentration of cholecalciferol that can vary, depending on the needs of supplement manufacturers, from 25,000 IU/g to 3,500 IU/g. The microcapsules ensure a uniform distribution and controlled release of the active ingredient, improving the absorption of vitamin D3 in the body.

IPS microcapsules can be used for the production of various solid oral formulations, such as hard capsules or single-dose orodispersible sachets, offering a versatile and highly effective solution to combat the deficiency of this essential element for our body.